n(g),n(g')-dimethyl-l-arginine has been researched along with Peripheral Arterial Disease in 13 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Peripheral Arterial Disease: Lack of perfusion in the EXTREMITIES resulting from atherosclerosis. It is characterized by INTERMITTENT CLAUDICATION, and an ANKLE BRACHIAL INDEX of 0.9 or less.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis causing endothelial dysfunction, an early sign of atherogenesis." | 5.37 | Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. ( Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B, 2011) |
| " All the patients were followed up for 5 years to determine the development of cardiovascular adverse events (CVAEs) and major amputation." | 1.48 | Role of microcirculatory function and plasma biomarkers in determining the development of cardiovascular adverse events in patients with peripheral arterial disease: A 5-year follow-up. ( Akkoca, M; Demirel Yilmaz, E; Köksoy, C; Tokgöz, S; Usanmaz, SE, 2018) |
| "Recent evidence suggests that abdominal obesity (AO) may play a role in PAD." | 1.39 | Abdominal obesity is associated with peripheral artery disease in hemodialysis patients. ( Hung, KY; Hung, PH; Lin, CH; Tsai, HB, 2013) |
| "Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO) synthesis causing endothelial dysfunction, an early sign of atherogenesis." | 1.37 | Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease. ( Atzler, D; Benndorf, RA; Böger, RH; Darius, H; Diehm, C; Endres, HG; Lüneburg, N; Maas, R; Schwedhelm, E; Thiem, U; von Stritzky, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, R | 1 |
| Yu, D | 1 |
| Chu, J | 1 |
| Lin, M | 1 |
| Yu, H | 1 |
| Paapstel, K | 1 |
| Kals, J | 1 |
| Eha, J | 1 |
| Tootsi, K | 1 |
| Ottas, A | 1 |
| Piir, A | 1 |
| Jakobson, M | 1 |
| Lieberg, J | 1 |
| Zilmer, M | 1 |
| Akkoca, M | 1 |
| Usanmaz, SE | 1 |
| Tokgöz, S | 1 |
| Köksoy, C | 1 |
| Demirel Yilmaz, E | 1 |
| Hung, PH | 1 |
| Tsai, HB | 1 |
| Lin, CH | 1 |
| Hung, KY | 1 |
| Yousefi, B | 1 |
| Faghfoori, Z | 1 |
| Samadi, N | 1 |
| Karami, H | 1 |
| Ahmadi, Y | 1 |
| Badalzadeh, R | 1 |
| Shafiei-Irannejad, V | 1 |
| Majidinia, M | 1 |
| Ghavimi, H | 1 |
| Jabbarpour, M | 1 |
| Kayacelebi, AA | 2 |
| Willers, J | 1 |
| Pham, VV | 1 |
| Hahn, A | 1 |
| Schneider, JY | 2 |
| Rothmann, S | 2 |
| Frölich, JC | 2 |
| Tsikas, D | 2 |
| Langen, J | 1 |
| Weigt-Usinger, K | 1 |
| Chobanyan-Jürgens, K | 1 |
| Mariotti, F | 1 |
| Atzler, D | 2 |
| Choe, CU | 1 |
| Schwedhelm, E | 2 |
| Huneau, JF | 1 |
| Lücke, T | 1 |
| Torondel, B | 1 |
| Nandi, M | 1 |
| Kelly, P | 1 |
| Wojciak-Stothard, B | 1 |
| Fleming, I | 1 |
| Leiper, J | 1 |
| Wilson, AM | 1 |
| Shin, DS | 1 |
| Weatherby, C | 1 |
| Harada, RK | 1 |
| Ng, MK | 1 |
| Nair, N | 1 |
| Kielstein, J | 1 |
| Cooke, JP | 1 |
| Böger, RH | 1 |
| Endres, HG | 1 |
| Darius, H | 1 |
| Lüneburg, N | 1 |
| von Stritzky, B | 1 |
| Maas, R | 1 |
| Thiem, U | 1 |
| Benndorf, RA | 1 |
| Diehm, C | 1 |
| Lilitkarntakul, P | 1 |
| Dhaun, N | 1 |
| Melville, V | 1 |
| Blackwell, S | 1 |
| Talwar, DK | 1 |
| Liebman, B | 1 |
| Asai, T | 1 |
| Pollock, J | 1 |
| Goddard, J | 1 |
| Webb, DJ | 1 |
| Tuygun, AK | 1 |
| Tuygun, A | 1 |
| Yurtseven, N | 1 |
| Sensöz, Y | 1 |
| Günay, R | 1 |
| Keser, M | 1 |
| Tuygun, UH | 1 |
| Ketenci, B | 1 |
| Sahin, S | 1 |
| Yekeler, I | 1 |
| Schlager, O | 1 |
| Giurgea, A | 1 |
| Schuhfried, O | 1 |
| Seidinger, D | 1 |
| Hammer, A | 1 |
| Gröger, M | 1 |
| Fialka-Moser, V | 1 |
| Gschwandtner, M | 1 |
| Koppensteiner, R | 1 |
| Steiner, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00284076] | 0 participants | Interventional | 2000-02-29 | Completed | |||
| Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)[NCT03883412] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-02-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for n(g),n(g')-dimethyl-l-arginine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Prognostic efficacy of circulating asymmetric dimethylarginine in patients with peripheral arterial disease: A meta-analysis of prospective cohort studies.
Topics: Arginine; Atherosclerosis; Biomarkers; Female; Humans; Male; Middle Aged; Peripheral Arterial Diseas | 2018 |
4 trials available for n(g),n(g')-dimethyl-l-arginine and Peripheral Arterial Disease
8 other studies available for n(g),n(g')-dimethyl-l-arginine and Peripheral Arterial Disease
| Article | Year |
|---|---|
Inverse relations of serum phosphatidylcholines and lysophosphatidylcholines with vascular damage and heart rate in patients with atherosclerosis.
Topics: Aged; Angiography, Digital Subtraction; Arginine; Biomarkers; Case-Control Studies; Coronary Artery | 2018 |
Role of microcirculatory function and plasma biomarkers in determining the development of cardiovascular adverse events in patients with peripheral arterial disease: A 5-year follow-up.
Topics: Arginine; Biomarkers; Blood Flow Velocity; C-Reactive Protein; Endothelium, Vascular; Female; Follow | 2018 |
Abdominal obesity is associated with peripheral artery disease in hemodialysis patients.
Topics: Adiponectin; Ankle Brachial Index; Arginine; C-Reactive Protein; Cross-Sectional Studies; Female; Hu | 2013 |
The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases.
Topics: Adult; Arginine; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Artery Disease; Endoth | 2014 |
Adenoviral-mediated overexpression of DDAH improves vascular tone regulation.
Topics: Adenoviridae; Amidohydrolases; Animals; Arginine; Carotid Arteries; Endothelial Cells; Gene Expressi | 2010 |
Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cerebrovascular Disorders; Enzyme Inhibitors; E | 2011 |
Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity.
Topics: Adult; Analysis of Variance; Arginine; Biomarkers; Blood Pressure; Brachial Artery; C-Reactive Prote | 2011 |
Asymmetric dimethylarginine levels in Buerger's disease.
Topics: Adult; Arginine; Biomarkers; Case-Control Studies; Chi-Square Distribution; Female; Humans; Male; Mi | 2011 |